|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - BIOGEN Inc (BIIB)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-04-30 Purchase |
2019-05-02 5:06 pm |
BIOGEN Inc | BIIB | DENNER ALEXANDER J Director |
118,342 | $229.9 | $27,211,824 | 643,000 (Direct Indirect) |
View |
| 2019-05-01 Purchase |
2019-05-02 4:30 pm |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
4,351 | $231.5 | $1,007,169 | 21,007 (Direct) |
View |
| 2019-03-18 Sale |
2019-03-19 4:08 pm |
BIOGEN Inc | BIIB | PANGIA ROBERT W Director |
6,114 | $328.5 | $2,008,755 | 24,701 (Direct) |
View |
| 2019-01-30 Purchase |
2019-02-01 4:19 pm |
BIOGEN Inc | BIIB | DENNER ALEXANDER J Director |
62,800 | $327.6 | $20,572,406 | 524,658 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-08-01 Tax Withholding |
2019-08-05 4:20 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
128 | $243.1 | 2,295 (Direct) |
View |
| 2019-08-01 Exercise |
2019-08-05 4:20 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
179 | $0 | 2,295 (Direct) |
View |
| 2019-08-01 Tax Withholding |
2019-08-05 4:20 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
80 | $243.1 | 2,295 (Direct) |
View |
| 2019-08-01 Exercise |
2019-08-05 4:20 pm |
N/A 2020-08-01 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
179 | $0 | 2,295 (Direct) |
View |
| 2019-08-01 Other |
2019-08-05 4:20 pm |
N/A 2020-08-01 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
247 | $0 | 2,295 (Direct) |
View |
| 2019-07-02 Exercise |
2019-07-05 4:51 pm |
N/A N/A |
BIOGEN Inc | BIIB | Karp Daniel VP |
196 | $0 | 1,564 (Direct) |
View |
| 2019-07-02 Tax Withholding |
2019-07-05 4:51 pm |
N/A N/A |
BIOGEN Inc | BIIB | Karp Daniel VP |
58 | $236.4 | 1,564 (Direct) |
View |
| 2019-07-02 Exercise |
2019-07-05 4:51 pm |
N/A 2021-07-02 |
BIOGEN Inc | BIIB | Karp Daniel VP |
196 | $0 | 1,564 (Direct) |
View |
| 2019-07-02 Other |
2019-07-05 4:51 pm |
N/A 2021-07-02 |
BIOGEN Inc | BIIB | Karp Daniel VP |
390 | $0 | 1,564 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 6:02 pm |
N/A N/A |
BIOGEN Inc | BIIB | Mantas Jesus B Director |
1,155 | $0 | 1,155 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 6:01 pm |
N/A N/A |
BIOGEN Inc | BIIB | HAWKINS WILLIAM A Director |
1,155 | $0 | 1,155 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 6:00 pm |
N/A N/A |
BIOGEN Inc | BIIB | SHERWIN STEPHEN A Director |
1,155 | $0 | 6,319 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:59 pm |
N/A N/A |
BIOGEN Inc | BIIB | SCHENK LYNN Director |
1,155 | $0 | 9,032 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:57 pm |
N/A N/A |
BIOGEN Inc | BIIB | Rowinsky Eric K Director |
1,155 | $0 | 16,179 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:55 pm |
N/A N/A |
BIOGEN Inc | BIIB | Posner Brian S Director |
1,155 | $0 | 8,050 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:54 pm |
N/A N/A |
BIOGEN Inc | BIIB | PAPADOPOULOS STELIOS Director |
1,905 | $0 | 17,375 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:52 pm |
N/A N/A |
BIOGEN Inc | BIIB | PANGIA ROBERT W Director |
1,155 | $0 | 19,742 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:51 pm |
N/A N/A |
BIOGEN Inc | BIIB | Mulligan Richard Director |
1,155 | $0 | 12,064 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:50 pm |
N/A N/A |
BIOGEN Inc | BIIB | LEAMING NANCY Director |
1,155 | $0 | 12,098 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:48 pm |
N/A N/A |
BIOGEN Inc | BIIB | DORSA CAROLINE Director |
1,155 | $0 | 20,207 (Direct) |
View |
| 2019-06-19 Option Award |
2019-06-20 5:47 pm |
N/A N/A |
BIOGEN Inc | BIIB | DENNER ALEXANDER J Director |
1,155 | $0 | 643,000 (Direct) |
View |
| 2019-06-01 Tax Withholding |
2019-06-04 4:56 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
460 | $219.3 | 8,525 (Direct) |
View |
| 2019-06-01 Exercise |
2019-06-04 4:56 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,126 | $0 | 8,525 (Direct) |
View |
| 2019-06-01 Tax Withholding |
2019-06-04 4:56 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
500 | $219.3 | 8,525 (Direct) |
View |
| 2019-06-01 Exercise |
2019-06-04 4:56 pm |
N/A 2019-06-01 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,126 | $0 | 8,525 (Direct) |
View |
| 2019-06-01 Other |
2019-06-04 4:56 pm |
N/A 2019-06-01 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,376 | $0 | 8,525 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:20 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
1,480 | $0 | 22,487 (Direct) |
View |
| 2019-05-02 Tax Withholding |
2019-05-06 4:20 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
658 | $230.5 | 22,487 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:20 pm |
N/A 2019-05-02 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
1,480 | $0 | 22,487 (Direct) |
View |
| 2019-05-02 Other |
2019-05-06 4:20 pm |
N/A 2019-05-02 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
1,772 | $0 | 22,487 (Direct) |
View |
| 2019-03-18 Exercise |
2019-03-19 4:08 pm |
N/A N/A |
BIOGEN Inc | BIIB | PANGIA ROBERT W Director |
6,114 | $52.22 | 24,701 (Direct) |
View |
| 2019-03-18 Exercise |
2019-03-19 4:08 pm |
2010-06-03 2019-06-02 |
BIOGEN Inc | BIIB | PANGIA ROBERT W Director |
6,114 | $53.43 | 24,701 (Direct) |
View |
| 2019-03-01 Tax Withholding |
2019-03-05 4:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
405 | $334.1 | 7,488 (Direct) |
View |
| 2019-03-01 Exercise |
2019-03-05 4:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
568 | $0 | 7,488 (Direct) |
View |
| 2019-03-01 Tax Withholding |
2019-03-05 4:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
253 | $334.1 | 7,488 (Direct) |
View |
| 2019-03-01 Exercise |
2019-03-05 4:17 pm |
N/A 2019-03-01 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
568 | $0 | 7,488 (Direct) |
View |
| 2019-03-01 Other |
2019-03-05 4:17 pm |
N/A 2019-03-01 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
280 | $0 | 7,488 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:09 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,663 | $0 | 36,085 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:09 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
6,395 | $48.52 | 36,085 (Direct) |
View |
| 2019-02-22 Tax Withholding |
2019-02-26 5:09 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
3,370 | $325.3 | 36,085 (Direct) |
View |
| 2019-02-22 Tax Withholding |
2019-02-26 5:09 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
739 | $325.3 | 36,085 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:09 pm |
N/A 2019-02-22 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,663 | $0 | 36,085 (Direct) |
View |
| 2019-02-22 Other |
2019-02-26 5:09 pm |
N/A 2019-02-22 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
819 | $0 | 36,085 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:09 pm |
N/A 2019-02-24 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
6,395 | $49.65 | 36,085 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,663 | $0 | 11,148 (Direct) |
View |
| 2019-02-22 Tax Withholding |
2019-02-26 5:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
739 | $325.3 | 11,148 (Direct) |
View |
| 2019-02-22 Exercise |
2019-02-26 5:07 pm |
N/A 2019-02-22 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,663 | $0 | 11,148 (Direct) |
View |
| 2019-02-22 Other |
2019-02-26 5:07 pm |
N/A 2019-02-22 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
819 | $0 | 11,148 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
5,269 | $0 | 18,914 (Direct) |
View |
| 2019-02-15 Tax Withholding |
2019-02-20 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
2,340 | $332.9 | 18,914 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:10 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
5,269 | $0 | 18,914 (Direct) |
View |
| 2019-02-15 Other |
2019-02-20 6:10 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
3,229 | $0 | 18,914 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:08 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,318 | $0 | 10,071 (Direct) |
View |
| 2019-02-15 Tax Withholding |
2019-02-20 6:08 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
586 | $332.9 | 10,071 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:08 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,318 | $0 | 10,071 (Direct) |
View |
| 2019-02-15 Other |
2019-02-20 6:08 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
808 | $0 | 10,071 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,448 | $0 | 7,968 (Direct) |
View |
| 2019-02-15 Tax Withholding |
2019-02-20 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
643 | $332.9 | 7,968 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 6:07 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,448 | $0 | 7,968 (Direct) |
View |
| 2019-02-15 Other |
2019-02-20 6:07 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
888 | $0 | 7,968 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 5:54 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,685 | $0 | 8,526 (Direct) |
View |
| 2019-02-15 Tax Withholding |
2019-02-20 5:54 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
749 | $332.9 | 8,526 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 5:54 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,685 | $0 | 8,526 (Direct) |
View |
| 2019-02-15 Other |
2019-02-20 5:54 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,033 | $0 | 8,526 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 5:53 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,685 | $0 | 28,776 (Direct) |
View |
| 2019-02-15 Tax Withholding |
2019-02-20 5:53 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
749 | $332.9 | 28,776 (Direct) |
View |
| 2019-02-15 Exercise |
2019-02-20 5:53 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,685 | $0 | 28,776 (Direct) |
View |
| 2019-02-15 Other |
2019-02-20 5:53 pm |
N/A 2020-02-15 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,033 | $0 | 28,776 (Direct) |
View |
| 2019-02-14 Gift |
2019-02-15 4:21 pm |
N/A N/A |
BIOGEN Inc | BIIB | Posner Brian S Director |
315 | $0 | 6,895 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:33 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
6,899 | $0 | 37,570 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:33 pm |
N/A N/A |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
2,622 | $319.4 | 37,570 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:33 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
6,899 | $0 | 37,570 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:33 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
5,205 | $0 | 37,570 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:33 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Vounatsos Michel CEO |
37,570 | $0 | 37,570 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,104 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
358 | $319.4 | 10,330 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
588 | $319.4 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,965 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
873 | $319.4 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,574 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:29 pm |
N/A N/A |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
699 | $319.4 | 10,330 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:29 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
10,330 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A 2020-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,104 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A 2019-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,965 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:29 pm |
N/A 2019-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,453 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:29 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,574 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:29 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Sandrock Alfred EVP Chief Medical Officer |
1,188 | $0 | 10,330 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,263 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
380 | $319.4 | 10,960 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,799 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | McKenzie Paul VP |
539 | $319.4 | 10,960 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:17 pm |
N/A 2020-02-12 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,263 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:17 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,799 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:17 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
1,357 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:17 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | McKenzie Paul VP |
10,960 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:15 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Kramer Robin CAO |
860 | $0 | 860 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:13 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Karp Daniel VP |
6,260 | $0 | 6,260 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:11 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Guindo Chirfi VP |
10,960 | $0 | 10,960 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
758 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
234 | $319.4 | 6,890 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
1,078 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:10 pm |
N/A N/A |
BIOGEN Inc | BIIB | Gregory Ginger VP |
317 | $319.4 | 6,890 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:10 pm |
N/A 2020-02-12 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
758 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:10 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
1,078 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:10 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
814 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:10 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Gregory Ginger VP |
6,890 | $0 | 6,890 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,578 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
469 | $319.4 | 13,460 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
2,249 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:07 pm |
N/A N/A |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
798 | $319.4 | 13,460 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:07 pm |
N/A 2020-02-12 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,578 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:07 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
2,249 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:07 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
1,697 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:07 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | Ehlers Michael D VP |
13,460 | $0 | 13,460 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:05 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | CAPELLO JEFFREY D CFO |
12,520 | $0 | 12,520 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:04 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,348 | $0 | 27,710 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:04 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
402 | $319.4 | 27,710 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:04 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,920 | $0 | 27,710 (Direct) |
View |
| 2019-02-12 Tax Withholding |
2019-02-14 6:04 pm |
N/A N/A |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
619 | $319.4 | 27,710 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:04 pm |
N/A 2020-02-12 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,348 | $0 | 27,710 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 6:04 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,920 | $0 | 27,710 (Direct) |
View |
| 2019-02-12 Other |
2019-02-14 6:04 pm |
N/A 2021-02-12 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
1,448 | $0 | 27,710 (Direct) |
View |
| 2019-02-12 Option Award |
2019-02-14 6:04 pm |
N/A 2022-02-12 |
BIOGEN Inc | BIIB | ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. |
10,020 | $0 | 27,710 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-04 4:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | CAPELLO JEFFREY D CFO |
1,331 | $0 | 7,649 (Direct) |
View |
| 2019-01-02 Tax Withholding |
2019-01-04 4:17 pm |
N/A N/A |
BIOGEN Inc | BIIB | CAPELLO JEFFREY D CFO |
414 | $304.7 | 7,649 (Direct) |
View |
| 2019-01-02 Exercise |
2019-01-04 4:17 pm |
N/A 2021-01-02 |
BIOGEN Inc | BIIB | CAPELLO JEFFREY D CFO |
1,331 | $0 | 7,649 (Direct) |
View |
| 2019-01-02 Other |
2019-01-04 4:17 pm |
N/A 2021-01-02 |
BIOGEN Inc | BIIB | CAPELLO JEFFREY D CFO |
1,661 | $0 | 7,649 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 16 Oct 2019 23:03:40 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |